Neurocrine Biosciences, Inc. NBIX
NasdaqGS β’ Real-Time Technical Indicators & Signals β’ Currency: USD
Automated Algorithmic Diagnosis
REAL-TIMEAlgorithmic Technical Summary for Neurocrine Biosciences, Inc. (NBIX): As of current market pricing, NBIX is trading at $156.59 (-6.27 (-3.85%)). Technical indicator diagnostics show a 14-day Relative Strength Index (RSI) of 49.22, indicating a Neutral Consolidation condition. The daily MACD (Moving Average Convergence Divergence) indicator is currently registered at 4.9 versus the signal line of 5.47, giving a histogram reading of -0.58 (Bearish Crossover). From a structural trend perspective, NBIX is trading +3.74% above its 200-day exponential moving average ($150.94), classifying the prevailing institutional trend bias as Neutral Consolidation.
NBIX Price & Trend Overlay (Last 90 Days)
Looking to buy or trade Neurocrine Biosciences, Inc. (NBIX)?
Trade TSX and US stocks with low commissions on Questrade. Open a TFSA, RRSP, or Margin account and receive a $50 cash reward with promo code 386513194498114.
Technical Indicators & Market Metrics Table
| Indicator / Metric | Current Value | Technical Status | Market Interpretation |
|---|---|---|---|
| RSI (14) | 49.22 | Neutral Consolidation | RSI at 49.22 is centered near 50, reflecting rangebound consolidation. |
| MACD Line (12, 26) | 4.9 | Bearish Crossover | Signal line: 5.47, Histogram: -0.58 |
| 20-Day EMA | $159.35 | Bearish | Short-term momentum guide. Price is trading under $159.35. |
| 50-Day EMA | $154.4 | Bullish | Medium-term trend indicator. Institutional support/resistance band. |
| 200-Day EMA | $150.94 | Long-Term Uptrend | Major institutional baseline. Distance to 200 EMA: +3.74%. |
| Average True Range (ATR 14) | $5.44 | Volatility | Expected average daily dollar price fluctuation. |
| 52-Week Range | $122.14 - $186.12 | Annual Range | Current price is $156.59 within the 52-week envelope. |
| Volume vs 30d Avg | 1.35M / 1.41M | Liquidity | Market Cap: 15.85B β’ P/E Ratio: 23.2 |
Technical Setups From Our Latest Scan
Stocks currently flagged by our RSI, MACD and EMA scan. See the full lists: oversold stocks Β· overbought stocks Β· MACD crossovers Β· Golden Cross Β· EMA screener Β· TSX scanner.
Frequently Asked Questions about Neurocrine Biosciences, Inc. (NBIX)
Q: What is NBIX's RSI (Relative Strength Index) today?
As of today, Neurocrine Biosciences, Inc. (NBIX) has a 14-day RSI of 49.22. This indicates a Neutral Consolidation condition. Traders use RSI readings below 30 to identify oversold conditions and readings above 70 to identify overbought conditions.
Q: Is NBIX's MACD indicator bullish or bearish?
The daily MACD line for NBIX is currently 4.9 compared to its 9-day signal line of 5.47, generating a histogram difference of -0.58. This translates to a Bearish Crossover signal.
Q: Where is NBIX trading relative to its 200-day EMA?
NBIX is currently trading at $156.59, which is +3.74% above its 200-day exponential moving average of $150.94. Staying above the 200 EMA is considered a primary benchmark for institutional bull market trends.
Q: What are key support and resistance levels for NBIX?
Immediate support sits around the 20-day EMA ($159.35) and recent 20-day swing low ($142.70). Immediate resistance is marked near the 20-day high ($174.41) and the 52-week high of $186.12.